Start Forschung Personen

Personen

Dr. Frank Enning

Tel.: 0621 1703-4181

E-Mail

K 3, 21, 3. OG, Raum 315

 

Sekretariat: Esther Wirth
Tel.: 0621 1703-4022, E-Mail

K 3, 21, 3. OG, Raum 312

Publikationen in peer-reviewed Zeitschriften seit 2006

TOP 5 Publikationen:

  1. Rivolta D, Castellanos NP, Stawowsky C, Helbling S, Wibral M, Grützner C, Koethe D, Birkner K, Kranaster L, Enning F, Singer W, Leweke FM, Uhlhaas PJ. Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing. J Neurosci. 2014 34(17):5909-17.
  2. Ceccarini J, De Hert M, van Winkel R, Peuskens J, Bormans G, Kranaster L, Enning F, Koethe D, Leweke FM, Van Laere K. Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia. Neuroimage. 2013 79:304-312. Epub 2013 Apr 25.
  3. Severance EG, Gressitt KL, Alaedini A, Rohleder C, Enning F, Bumb JM, Müller JK, Schwarz, Ph.D E, Yolken RH, Leweke FM. IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia. Brain Behav Immun. 2015 44:148-58. Epub 2014 Sep 19.
  4. Englisch S, Eer A, Enning F, Hohmann S, Schanz H, Zink M. Augmentation With Pregabalin in Schizophrenia. J Clin Psychopharmacol. 2010 30(4):437-40. Epub 2010 May 29.
  5. Bumb JM, Enning F, Leweke FM. Drug repurposing and emerging adjunctive treatments for schizophrenia. Expert Opin Pharmacother. 2015 16(7):1049-67. Epub 2015 Apr 12.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de